CHU de LILLE - Bureau des ARCs Gastro - HPDD

Lille 59037

0 studies enrolling now · 1 studies all time

What they study most

Ulcerative Colitis, Ulcerative Colitis Chronic

Studies at this site

• A Study of Mirikizumab (LY3074828) in Participants With Moderately to Severely Active Ulcerative Colitis — Completed